Literature DB >> 20488324

The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms.

Hazem Abdul-Hussien1, Roeland Hanemaaijer, Robert Kleemann, Ben F J Verhaaren, J Hajo van Bockel, Jan H N Lindeman.   

Abstract

OBJECTIVE: There is remarkable controversy over the processes driving abdominal aneurysm growth. The inherent limitations of animal and human studies hamper elucidation of the key inflammatory and proteolytic processes. Human data are largely derived from surgical specimens that typically reflect the final stages of the disease process and thus do not allow distinction between primary and secondary processes. Clear epidemiologic and genetic associations between abdominal aortic aneurysm (AAA) and popliteal artery aneurysms (PAA) suggest that that these two pathologies share common grounds. On this basis, we reasoned that information of corresponding and discordant processes in these aneurysms might provide critical clues on the processes that are crucial for aneurysm progression.
METHODS: Messenger RNA (semi-quantitative real-time polymerase chain reaction) and protein analysis (enzyme-linked immunosorbent assay, multiplex, Western blotting), and histology were performed on aneurysm wall samples obtained during elective PAA and AAA repair. Nonaneurysmal aorta tissue from organ donors was included as reference.
RESULTS: Messenger RNA and protein analysis showed that PAA and AAA are both characterized by a marked activation of nuclear factor-kappaB (NF-kappaB) and activator protein-1 (AP-1) proinflammatory transcription factors, and hyperexpression of interleukin (IL)-6 and IL-8. Discordant findings were found for other inflammatory markers such as interferon-gamma, interferon-inducible protein 10, tumor necrosis factor-alpha, monocyte chemotactic protein-1, and macrophage inflammatory protein 1alpha and beta, which were all lower in PAA. On the cellular level, both pathologies exhibited profuse infiltration of macrophages, neutrophils, and T-helper cells. Results for B cells, plasma cells, and cytotoxic T cells were discordant, with minimal infiltration of these cell types in PAA. Evaluation of protease expression and activation showed that both conditions are dominated by increased matrix metalloproteinase 8 and 9, and cathepsin K, L and S expression and activation.
CONCLUSION: This explorative study characterizes degenerative aneurysmal disease general inflammatory conditions that are dominated by profound activation of the NF-kappaB and AP-1 pathways, hyperexpression of IL-6 and IL-8, and neutrophil involvement. Discordant findings for interferon gamma, cytotoxic T cells, B cells, and plasma cells challenge a critical role for these factors in the process of aneurysm growth. Pharmaceutic strategies targeting the common components in AAA and PAA may prove effective for the stabilization of AAA. Copyright (c) 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488324     DOI: 10.1016/j.jvs.2010.01.057

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  43 in total

1.  Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients.

Authors:  Padmini S Pillai; Stanley Leeson; Timothy F Porter; Christopher D Owens; Ji Min Kim; Michael S Conte; Charles N Serhan; Simon Gelman
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

2.  Role of complement cascade in abdominal aortic aneurysms.

Authors:  Irene Hinterseher; Robert Erdman; Larry A Donoso; Tamara R Vrabec; Charles M Schworer; John H Lillvis; Amy M Boddy; Kimberly Derr; Alicia Golden; William D Bowen; Zoran Gatalica; Nikos Tapinos; James R Elmore; David P Franklin; John L Gray; Robert P Garvin; Glenn S Gerhard; David J Carey; Gerard Tromp; Helena Kuivaniemi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-14       Impact factor: 8.311

3.  Vessel wall morphology is equivalent for different artery types and localizations of advanced human aneurysms.

Authors:  Albert Busch; Caroline Grimm; Elena Hartmann; Valentina Paloschi; Ralph Kickuth; Mariette Lengquist; Christoph Otto; Per Eriksson; Richard Kellersmann; Udo Lorenz; Lars Maegdefessel
Journal:  Histochem Cell Biol       Date:  2017-05-06       Impact factor: 4.304

4.  Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

Authors:  Yanwen Qin; Xu Cao; Jun Guo; Yaozhong Zhang; Lili Pan; Hongjia Zhang; Huihua Li; Chaoshu Tang; Jie Du; Guo-Ping Shi
Journal:  Cardiovasc Res       Date:  2012-08-07       Impact factor: 10.787

5.  Relevance of inflammation and matrix remodeling in abdominal aortic aneurysm (AAA) and popliteal artery aneurysm (PAA) progression.

Authors:  Martina Ramella; Priscilla Bernardi; Luca Fusaro; Marcello Manfredi; Francesco Casella; Carla M Porta; Laura Nicolai; Edoardo Galeazzi; Renzo Boldorini; Alberto M Settembrini; Piergiorgio Settembrini; Emilio Marengo; Mario Cannas; Francesca Boccafoschi
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

6.  Discovery of crucial cytokines associated with abdominal aortic aneurysm formation by protein array analysis.

Authors:  Yuan Li; Dan Yang; Bo Sun; Xu Zhang; Fangda Li; Zhili Liu; Yuehong Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-31

7.  Non-invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT): Design of a Phase IIb, placebo-controlled, double-blind, randomized clinical trial of doxycycline for the reduction of growth of small abdominal aortic aneurysm.

Authors:  B Timothy Baxter; Jon Matsumura; John Curci; Ruth McBride; William C Blackwelder; Xinggang Liu; LuAnn Larson; Michael L Terrin
Journal:  Contemp Clin Trials       Date:  2016-03-25       Impact factor: 2.226

Review 8.  MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm.

Authors:  Yongqi Li; Weicheng Wang; Lei Li; Raouf A Khalil
Journal:  Life Sci       Date:  2020-04-10       Impact factor: 5.037

9.  Experimental model for coadjuvant treatment with mesenchymal stem cells for aortic aneurysm.

Authors:  Luis Riera Del Moral; Carlota Largo Aramburu; José Ramón Ramírez García; Luis Riera de Cubas; Damián García-Olmo; Mariano García-Arranz
Journal:  Am J Stem Cells       Date:  2012-11-30

10.  Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Authors:  William F Johnston; Morgan Salmon; Gang Su; Guanyi Lu; Matthew L Stone; Yunge Zhao; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.